XBKK
DDD
Market cap54mUSD
Nov 12, Last price
5.80THB
Name
Do Day Dream PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Do Day Dream Public Company Limited, operating with its subsidiaries in Thailand, specializes in the manufacturing and distribution of skincare items and nutritional supplements. The company's operations are divided into its Skincare business and Beauty Products business segments. It manages a diverse portfolio of brands, offering products such as OXE'CURE for sensitive and acne-prone skin, SOS for deep-nourishing skincare, and LESASHA for hair styling appliances. Its oral care line includes toothpastes and toothbrushes under SPARKLE, while Kuron provides various beauty innovations. Additionally, Do Day Dream markets fitness equipment through JASON, general home electrical appliances via AT HOME, and cooking electrical appliances under the BEAR brand. The firm also provides hair removal solutions, including EMJOI devices and intense pulsed light (IPL) technology under SMOOTH SKIN. Established in 2010, Do Day Dream maintains its corporate headquarters in Bangkok, Thailand.
Key people
Nuntawan Suwandej
Chief Executive Officer, Executive Director · since 2021
Vanchai Srisuchon
Chief Accounting and Finance Officer · since 2021
Nitiroj Manolamai
Executive Director, Acting Company Secretary, Acting Head - Compliance Department · since 2021
Sarawut Pornpatanarak
Executive Vice Chairman of the Board · since 2018
Rittikrai Thammaraksa
Executive Chairman of the Board · since 2021
Suphawat Vanichprapha
Executive Director · since 2021
Non-Executive Director · since 2018
Wasin Parithan
Non-Executive Independent Director · since 2021
Terdsak Rojsurakitti
Non-Executive Independent Director · since 2019
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||